This preparation contains three different monoclonal antibodies and reacts with murine integrin alpha2 chain (CD49b), that is part of the integrin alpha2 beta1 complex known as VLA-2, a receptor for collagen and laminin, expressed on platelets, epithelial cells, and activated lymphocytes.